Systematic, network-based characterization of therapeutic target inhibitors.
A large fraction of the proteins that are being identified as key tumor dependencies represent poor pharmacological targets or lack clinically-relevant small-molecule inhibitors. Availability of fully generalizable approaches for the systematic and efficient prioritization of tumor-context specific...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-10-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC5638208?pdf=render |